Papers matching “pathological complete response” 174
Not finding it? Sign in to also search OpenAlex live.
-
89Zr-Trastuzumab PET/CT Imaging of HER2-Positive Breast Cancer for Predicting Pathological Complete Response after Neoadjuvant Systemic Therapy: A Feasibility Study
Daan G. J. Linders, Marion M. Deken, Martijn A. van Dam, Martin N.J.M. Wasser, Eleonora M. C. Voormolen, Judith R. Kroep, +13 more
17citations -
Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial
W.H. Zwart, Sofieke J. D. Temmink, Geke A.P. Hospers, Corrie A.M. Marijnen, Hein Putter, Irıs D. Nagtegaal, +9 more
43citations -
Predictors of- and oncological outcomes after a pathological complete response following total neoadjuvant treatment or chemoradiotherapy for locally advanced rectal cancer in the RAPIDO trial
Sofieke J. D. Temmink, W.H. Zwart, Geke A.P. Hospers, Corrie A.M. Marijnen, Bengt L. G. Glimelius, Cornelis J.�H. van de Velde, +3 more
0citations -
A review of the association between baseline [18F] fluorodeoxyglucose uptake and axillary pathological complete response in node-positive breast cancer patients: focus on clinical subtypes2025 Nuclear Medicine Communications article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Melissa Lenaerts, Florien J G van Amstel, Felix Manuel Mottaghy, Sandra M. E. Geurts, Vivianne C. G. Tjan‐Heijnen, Marjolein L. Smidt, +1 more
5citations -
Oncological Outcomes after a Pathological Complete Response Following Total Neoadjuvant Therapy or Chemoradiotherapy for High-Risk Locally Advanced Rectal Cancer in the RAPIDO Trial
W.H. Zwart, Sofieke J. D. Temmink, Geke A.P. Hospers, Corrie A.M. Marijnen, H. Putter, Irıs D. Nagtegaal, +9 more
2citations -
Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12‐week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials
Monika Graeser, Simone Schrading, Oleg Gluz, Kevin Strobel, Rachel Würstlein, Sherko Kümmel, +15 more
12citations -
MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study
Renée W. Y. Granzier, Abdalla Ibrahim, Sergey P. Primakov, Sanaz Samiei, Thiemo J. A. van Nijnatten, Maaike de Boer, +7 more
42citations -
Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype
Cornelis Maarten de Mooij, Cristina Mitea, Felix Manuel Mottaghy, Marjolein L. Smidt, Thiemo J. A. van Nijnatten
13citations -
Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2 ‐negative early breast cancer2021 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Sophie C. Hagenaars, Stefanie de Groot, Danielle B. Cohen, Tim J. A. Dekker, Ayoub Charehbili, Elma Meershoek‐Klein Kranenbarg, +6 more
43citations -
Abstract PS10-07: Pathologic complete response and 3-year survival with or without pertuzumab using real-world data of stage II and III HER2-positive breast cancer
Anna van der Voort, Marte C. Liefaard, Mette van Ramshorst, Erik D. van Werkhoven, Astrid N. Scholten, Jelle Wesseling, +3 more
0citations -
Tumor-stroma ratio is associated with Miller-Payne and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer2020 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Sophie C. Hagenaars, S de Groot, Danielle B. Cohen, Ayoub Charehbili, Tim J. A. Dekker, Elma Meershoek‐Klein Kranenbarg, +6 more
3citations -
Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer
Cornelis Maarten de Mooij, Thiemo J. A. van Nijnatten, Briete Goorts, Loes F. S. Kooreman, Isabel W. M. Raymakers, Silke P. L. van Meijl, +6 more
12citations -
On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer2024 Breast Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Bruno Valentin Sinn, Katharina Sychra, M. Untch, Thomas Karn, Marion van Mackelenbergh, Jens Huober, +13 more
8citations -
Response evaluation of neoadjuvant therapy in MIBC : clinical trial‐derived evidence to guide practice2026 British Journal of Urology article Medicine Bladder and Urothelial Cancer Treatments Open access
Roberto Contieri, Bas W.G. van Rhijn, Richard Cathomas, Anja Lorch, Daniela Oprea-Lager, Paramananthan Mariappan, +3 more
0citations -
Response to neoadjuvant treatment among rectal cancer patients in a population-based cohort2020 International Journal of Colorectal Disease article Medicine Colorectal Cancer Surgical Treatments Open access
Elizabeth Alwers, Lina Jansen, Jakob Nikolas Kather, Efrat L. Amitay, Hendrik Bläker, Matthias Kloor, +6 more
3citations -
Abstract P1-10-01: Caveolin gene expression predicts for response and clinical outcomes of patients treated with preoperative paclitaxel-based chemotherapy regimens in early stage breast cancer2020 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Terence Marques Williams, Andreas Schneeweiß, Christian Jackisch, Changxian Shen, Karsten Ernst Weber, Peter Andreas Fasching, +16 more
0citations -
BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer2023 Breast Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Marte C. Liefaard, Anna van der Voort, Mette S. van Ramshorst, Joyce Sanders, Shiva Vonk, Hugo M. Horlings, +10 more
6citations -
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial2023 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Peter Andreas Fasching, Christopher W. Szeto, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Patricia Spilman, +18 more
8citations -
Baseline CD4+ and expansion of γδ T cells correlate with response to durvalumab in triple‐negative breast cancer patients2024 Clinical and Translational Medicine article Medicine Cancer Immunotherapy and Biomarkers Open access
Chiara Massa, Thomas Karn, Karsten Ernst Weber, Andreas Schneeweiß, Claus Alexander Hanusch, Jens‐Uwe Blohmer, +16 more
2citations -
Data from Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial
Peter Andreas Fasching, Christopher W. Szeto, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Patricia Spilman, +18 more
1citations